AGR3 and breast carcinoma: The role of AGR3 in the clinic of breast cancer remains nuclear,5, 12due to the limited studies that present the clinicopathological and prognostic relevance of this protein.5However, the evidence suggest that AGR3 may be associated with oncogenesis, and it has been pointed out as a potential therapeutic target and prognostic biomarker for patients with breast cancer.